maximum weight loss tirzepatide surmount trials SURMOUNT-3: shows total mean of 26.6% from study entry over 84 weeks SURMOUNT-1: In an RCT, adults

The gradual dose titration for both medications is designed to minimise these effects

Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including statements about the supply and access of Zepbound (tirzepatide) as a treatment for adults with obesity or overweight and reflects Lilly's current belief and expectations

For women navigating weight management, our guides on peptides for weight loss in women and peptides for menopause weight loss address the specific physiological considerations that affect female dosing and response

PlexusDx Precision Peptide Genetic Testing can help identify which medication aligns with your genetic fat-metabolism profile for optimal results

DISCLAIMER If you have any medical questions or concerns, please talk to your healthcare provider

Practical management strategies For nausea: Eat smaller, more frequent meals throughout the day instead of three large ones